A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 4, Pages e01505-17
Publisher
American Society for Microbiology
Online
2018-01-17
DOI
10.1128/aac.01505-17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
- (2017) Ujjini H. Manjunatha et al. NATURE
- A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis
- (2017) Melissa S. Love et al. PLoS Neglected Tropical Diseases
- Continuous culture of Cryptosporidium parvum using hollow fiber technology
- (2016) Mary Morada et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
- (2016) Deborah A. Schaefer et al. JOURNAL OF INFECTIOUS DISEASES
- Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
- (2016) Jie Liu et al. LANCET
- Natural History of Cryptosporidiosis in a Longitudinal Study of Slum-Dwelling Bangladeshi Children: Association with Severe Malnutrition
- (2016) Poonum S. Korpe et al. PLoS Neglected Tropical Diseases
- Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
- (2016) Wesley C. Van Voorhis et al. PLoS Pathogens
- A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
- (2015) William Checkley et al. LANCET INFECTIOUS DISEASES
- A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments
- (2015) Christopher D. Huston et al. PLoS Neglected Tropical Diseases
- Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice
- (2015) Karine Sonzogni-Desautels et al. Frontiers in Microbiology
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
- (2015) James A Platts-Mills et al. Lancet Global Health
- Identification of Cryptosporidium parvum Active Chemical Series by Repurposing the Open Access Malaria Box
- (2014) K. Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of IMP Dehydrogenase Inhibitors in a Mouse Model of Cryptosporidiosis
- (2013) Suresh Kumar Gorla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Cysteine Protease Inhibitor Rescues Mice from a Lethal Cryptosporidium parvum Infection
- (2013) Momar Ndao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
- (2013) Kovi Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Calcium-Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis
- (2013) Alejandro Castellanos-Gonzalez et al. JOURNAL OF INFECTIOUS DISEASES
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Designing the next generation of medicines for malaria control and eradication
- (2013) Jeremy N Burrows et al. MALARIA JOURNAL
- Description of fecal shedding of Cryptosporidium parvum oocysts in experimentally challenged dairy calves
- (2013) Jennifer A. Zambriski et al. PARASITOLOGY RESEARCH
- Structural Determinants of Inhibitor Selectivity in Prokaryotic IMP Dehydrogenases
- (2010) Deviprasad R. Gollapalli et al. CHEMISTRY & BIOLOGY
- Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
- (2010) Ryan C. Murphy et al. ACS Medicinal Chemistry Letters
- High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
- (2009) Beatrice Amadi et al. BMC INFECTIOUS DISEASES
- Triazole Inhibitors ofCryptosporidium parvumInosine 5′-Monophosphate Dehydrogenase
- (2009) Sushil K. Maurya et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
- (2008) Iñigo Angulo-Barturen et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started